Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
IMMOGLAB from Glabbeek, company number BE0442007224, closed financial year 2025 with a result of € -3,346 after tax. For that financial year IMMOGLAB recorded a gross margin of € 7,497 and equity of € 518,273. Compared with financial year 2024, the result moved from € 429,556 to € -3,346. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 518,273
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -3,346
▼ still € 429,556 profit in 2024
Profit after tax over the fiscal year.
€ 97,101
▲ 105% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 456,773.
Debts at end 2025
€ 32,828
Loans from banks and other lenders, long and short.
€ 1,696
▲ 175% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 49,173
▼ 1% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,701 | € 17,189 | € 648,422 | € 7,497 | ▼ 99% |
| Profit after taxes | € -32,452 | € -17,578 | € 429,556 | € -3,346 | ▼ € 432,902 |
| Equity | € 624,439 | € 92,064 | € 521,619 | € 518,273 | ▼ 1% |
| Total debts | € 46,299 | € 555,101 | € 582,220 | € 568,172 | ▼ 2% |
| Cash | € 408,315 | € 376,742 | € 47,287 | € 97,101 | ▲ 105% |
| Land & buildings | € 203,047 | € 190,469 | € 138,228 | € 125,650 | ▼ 9% |
| Retained profit | € 49,326 | € 30,564 | € 460,119 | € 456,773 | ▼ 1% |
| Dividend | € 0 | € 1,184 | € 0 | € 0 | |
| Bank debt | € 40,447 | € 32,828 | € 32,828 | € 32,828 | |
| Balance sheet total | € 670,738 | € 647,165 | € 1,103,839 | € 1,086,445 | ▼ 2% |
Key figures of IMMOGLAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to IMMOGLAB?
What happened at IMMOGLAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 3,346 (▼ € 432,902 vs 2024). Source: NBB ↗
- Jan Houben became a director. NBB
- Katrijn Spiritus became a director. NBB
- New establishment in Glabbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 32,452 loss in 2022 to € 3,346 loss in 2025.
Paid € 192,908 in corporate taxes since 2022.
Best year ever: 2024, with € 429,556 profit.
Paid out € 1,184 in dividends to the owners in total.
Management
Behind IMMOGLAB are Jan Houben, Katrijn Spiritus and Elke Kempeneers. Katrijn Spiritus is also behind HOESELTPHARMA. Elke Kempeneers is also behind ELBEFAR.
Directors
According to the 2025 annual accounts
Jan Houben
Director
since 2025
since 2012
Establishments
Establishment units
Physical locations of this company
Steenbergestraat 48
3380 Glabbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0442.007.224
- VAT number
- BE 0442.007.224
- Registered office
- Steenbergestraat 48, 3380 Glabbeek
- Names & denominations
- IMMOGLAB
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 13 September 1990
- Peppol
- Active · Active since 4 Dec 2025